Showing results (41-50 of 464) with videos related to
Sort By:
Pageof 47
Expert Opinion on Biological Therapy|December 8, 2006
Interleukin-18 as a potential therapeutic target in chronic autoimmune/inflammatory conditionsMichele Bombardieri, Iain B McInnes, Costantino PitzalisAnnals of the Rheumatic Diseases|February 2, 2012
Cardiovascular and metabolic risks in psoriasis and psoriatic arthritis: pragmatic clinical management based on available evidenceHanna Johnsson, Iain B McInnes, Naveed SattarRheumatology (Oxford, England)|June 7, 2021
Effect of the phosphodiesterase 4 inhibitor apremilast on cardiometabolic outcomes in psoriatic disease-results of the Immune Metabolic Associations in Psoriatic Arthritis studyLyn D Ferguson, Susanne Cathcart, Dominic Rimmer, et al.Immunology Letters|July 6, 2004
ES-62, a filarial nematode-derived immunomodulator with anti-inflammatory potentialWilliam Harnett, Iain B McInnes, Margaret M HarnettAnnual Review of Medicine|November 14, 2015
Therapeutic Targeting of IL-17 and IL-23 Cytokines in Immune-Mediated DiseasesGeorge E Fragoulis, Stefan Siebert, Iain B McInnesImmunity|December 14, 2022
The pathogenesis of rheumatoid arthritisStefano Alivernini, Gary S Firestein, Iain B McInnesNature Reviews. Rheumatology|February 20, 2013
Back to the future: oral targeted therapy for RA and other autoimmune diseasesJohn J O'Shea, Arian Laurence, Iain B McInnesNature Reviews. Rheumatology|March 2, 2026
Bridging the gap: combining treat-to-target and difficult-to-treat strategies in the management of rheumatoid arthritisLilla Gunkl-Tóth, Iain B McInnes, György NagyJournal of the American Academy of Dermatology|July 5, 2021
Tyrosine kinase 2 and Janus kinase‒signal transducer and activator of transcription signaling and inhibition in plaque psoriasisJames G Krueger, Iain B McInnes, Andrew BlauveltImmunology and Cell Biology|January 18, 2012
Novel regulatory mechanisms in inflammatory arthritis: a role for microRNADerek Baxter, Iain B McInnes, Mariola Kurowska-StolarskaPageof 47